Syringocystadenoma Papilliferum
Syringocystadenoma papilliferum (SCAP) is a rare benign epithelial growth that arises from the hair follicle, sebaceous gland and sweat gland complex (folliculosebaceous-apocrine unit). It is defined by papillae that project into funnel-shaped spaces (cystic invaginations), lined by a two-layered epithelium, with a dense infiltrate of plasma cells in the connective tissue cores.
About 30–50% of SCAPs develop within a congenital nevus sebaceus of Jadassohn, reflecting the developmental (hamartomatous) nature of these skin appendage structures.
MAPK/ERK Pathway Mutations (BRAF and RAS)
- BRAF V600E mutation: present in roughly 50–70% of SCAPs, both those arising de novo and those arising in a nevus sebaceus. This point mutation swaps valine for glutamic acid at codon 600 and keeps the MAPK/ERK signaling pathway permanently switched on.
- HRAS and KRAS mutations: tumors without BRAF mutations often carry activating mutations in HRAS (notably HRAS G13R or HRAS Q61L) or KRAS. A mosaic HRAS mutation in the nevus sebaceus, combined with an additional mutation, sets the stage for SCAP to emerge at puberty under the influence of androgens.
Plasma Cell Infiltration and the Immune Microenvironment
- The most distinctive histologic feature of SCAP is a dense collection of plasma cells (CD138+, MUM1+) in the stromal cores of the epithelial papillae.
- These plasma cells release large amounts of inflammatory cytokines (IL-6, TGF-beta), which drive papillary growth of the lining epithelium and keep the surface moist and secreting.
Although benign, SCAP can undergo secondary malignant change into syringocystadenocarcinoma papilliferum, or occur together with basal cell carcinoma (BCC) in a nevus sebaceus. Our protocol at Haute-Derma includes:
- Surface and microscopic imaging: high-magnification dermoscopy combined with 50 MHz skin ultrasound to measure how deep the tumor base extends.
- Complete removal by R0 micrographic surgery or Er:YAG laser ablation: the whole SCAP is removed together with the underlying nevus sebaceus to prevent later malignant change.
Histopathology and Immunohistochemistry (IHC) Criteria
Characteristic Microscopic Features
Under light microscopy, SCAP has a highly characteristic, hard-to-mistake appearance:
- Cup-shaped invaginations: the epidermis dips deeply downward, forming one or more funnels that open onto the skin surface.
- Papillary projections: numerous epithelial papillae grow from the funnel walls into the central space.
- Two-layered epithelium:
- Luminal (inner) layer: tall columnar cells with oval basal nuclei, eosinophilic cytoplasm and apocrine decapitation secretion at the cell tips.
- Basal (outer) layer: a single row of small flat to cuboidal basal cells that act as myoepithelial cells.
- Plasma cell-rich stroma (plasmacytic stroma): the fibrovascular cores of the papillae are packed with plasma cells, mixed with a few lymphocytes and neutrophils.
Immunohistochemistry (IHC) Panel
| IHC Marker / Stain | Staining Location in the Tumor | Diagnostic Significance |
|---|---|---|
| CEA / EMA | Apical surface of columnar cells lining the papillae | Strongly positive (+++); confirms sweat duct/apocrine differentiation |
| GCDFP-15 | Cytoplasm of columnar lining cells | Positive (+); confirms apocrine gland nature |
| CD138 / MUM1 | Plasma cells in the papillary cores | Specifically positive (+++); confirms the dense plasma cell infiltrate in the stroma |
| p63 / SMA | Outer myoepithelial cells | Clearly positive (++); confirms the preserved two-layered epithelium |
| BRAF V600E (VE1) | Cytoplasm of tumor epithelial cells | Positive or negative (+/−); helps identify the driver mutation (>50–70%) |
| Ki-67 index | Nuclei of dividing tumor cells | Low (<2–5%), in keeping with benign behavior (Ki-67 >20% raises concern for malignant change) |
High-Frequency Skin Ultrasound and Dermoscopy Criteria
- High-frequency skin ultrasound:
- Shape and borders: a mixed cystic and papillary structure (complex cystic-papillary lesion) with well-defined borders in the superficial and mid dermis.
- Echo pattern: a fluid-filled, anechoic cystic component with hyperechoic papillary projections extending into the cyst.
- Color Doppler: increased low-resistance blood flow in the cores of the epithelial papillae.
- Dermoscopy:
- Overall pattern: a papillomatous pattern made up of many pink-orange or skin-colored buds (pinkish-orange nodules).
- Central openings: central pores filled with disc-shaped secretion or dried crust (central umbilication with crust).
- Vascular pattern: cockscomb-like vessels, dotted vessels or hairpin vessels concentrated in the center of the buds.
Clinical Features
- Onset: often present at birth or appearing in early childhood (as an underlying nevus sebaceus), then growing rapidly into papillary nodules at puberty under the influence of androgens.
- Common sites: overwhelmingly the scalp and neck (>75–80%), followed by the face and trunk.
- Appearance: a granular papillomatous plaque or a single firm nodule with a bumpy, moist surface that readily oozes mucus or blood or forms a crust. Patients may notice mild itching or pain when it is knocked.
Multimodal Treatment at Haute-Derma
Because SCAP often arises in a nevus sebaceus and can progress to secondary malignant variants, Haute-Derma follows a standard of complete removal while preserving the function and appearance of the scalp and face:
Imaging and Mutation Testing
- Dermoscopy and 50 MHz ultrasound: assess how deep the tumor funnels reach into the dermis and where the surrounding nevus sebaceus ends.
- Confirmatory biopsy: stains for CEA, GCDFP-15, CD138 (to confirm plasma cells) and BRAF V600E. If atypical nuclei or increased mitoses are found, the surgical margins are widened.
Complete Removal With Clear (R0) Margins
R0 Micrographic Excision (Micro-Surgical Excision):
- Used for large SCAPs, lesions with a weeping or purulent surface, or those arising in an extensive nevus sebaceus.
- The surgeon removes the entire lesion together with the underlying nevus sebaceus, with a 2–3 mm microscopic safety margin extending down to the subcutaneous fat.
2940 nm Er:YAG / Fractional CO2 Laser Ablation:
- Suited to small, superficial SCAPs on the face or to patients who decline surgical excision.
- The 2940 nm Er:YAG laser (300 µs pulse mode) vaporizes the papillary tissue layer by layer until healthy stroma in the deep dermis is reached, followed by fractional CO2 laser for hemostasis and to stimulate skin regeneration.
Scalp Restoration and Preventing Recurrence
- Restoring bald patches on the scalp: for scalp lesions, we use a rotation or advancement flap, or micro-injections of stem cell exosomes with PDRN around the wound edge, to encourage hair regrowth and soften the scar.
- Low-level light therapy (LLLT, 633 nm): calms inflammation, suppresses opportunistic bacteria and speeds up healing of the epidermis.
- Regular follow-up: checkups every 6 months for the first 2 years to screen for secondary tumors in any nevus sebaceus that was not fully removed.
